Literature DB >> 2876542

[Enterotoxemia in newborn calves due to Cl. perfringens types A, C and D].

R Lulov, A K Angelov.   

Abstract

The clinical symptoms and the morphologic picture of calf enterotoxemia are described. Studied were a total of thirty-two dead and slaughtered animals. Bacteriologically, the disease was shown to be caused by types A, D, and C of Clostridium perfringens. Types C and D proved pathogenic for guinea pigs, while type A did not. Isolated was a strain of Clostridium perfringens, which had high toxigenicity. It was found that calves were fairly often affected with the disease. Most severe were the infections caused by type C of Cl. perfringens, with most pronounced morphologic lesions. There were differences in the changes caused by all three types of the organism in calves, which made it possible to distinguish them as causative agents. Type A induced slight icterus and slightly manifested hemosiderosis of the liver, kidneys, and spleen; type D was responsible for severe injury and hyalin dystrophy of the kidneys; and type C caused necrotic enteritis, pronounced hemorrhagic diathesis, degenerative changes in the ganglial cells, and demyelinization of the brain.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2876542

Source DB:  PubMed          Journal:  Vet Med Nauki        ISSN: 0324-1068


  3 in total

Review 1.  Clostridial enteric diseases of domestic animals.

Authors:  J G Songer
Journal:  Clin Microbiol Rev       Date:  1996-04       Impact factor: 26.132

2.  Clostridial abomasitis in calves: case report and review of the literature.

Authors:  J Glenn Songer; Dale W Miskimins
Journal:  Anaerobe       Date:  2005-04-25       Impact factor: 3.331

3.  Diversity of Clostridium perfringens toxin-genotypes from dairy farms.

Authors:  Svenja Fohler; Guenter Klein; Martina Hoedemaker; Theresa Scheu; Christian Seyboldt; Amely Campe; Katharina Charlotte Jensen; Amir Abdulmawjood
Journal:  BMC Microbiol       Date:  2016-08-30       Impact factor: 3.605

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.